TRAF6 peptide TFA is a specific inhibitor of TRAF6-p62 interactions. TRAF6 peptide TFA can eliminate NGF dependent TrkA ubiquitination. TRAF6 peptide TFA has good research potential in neurological diseases such as Alzheimer's disease (AD), Parkinson's disease, ALS, head trauma, epilepsy, and stroke.
TRAF6 peptide TFA 是一种特异性的 TRAF6-p62 相互作用抑制剂。TRAF6 peptide TFA 能消除 NGF 依赖性 TrkA 泛素化。TRAF6 peptide TFA 在诸如阿尔茨海默症 (AD)、帕金森、ALS、头部外伤、癫痫和中风等神经系统性疾病中具有较好的研究潜力。